COLUMBIA, Md., Jan 30, 2004 /PRNewswire-FirstCall via COMTEX/ -- Martek Biosciences Corporation (Nasdaq: MATK) today announced that it has filed a patent infringement suit in Germany against Nutrinova Nutrition Specialties & Food Ingredients GmbH and Celanese Ventures GmbH for patent infringement arising from Nutrinova's manufacture, sale and use of a fatty acid product marketed by Nutrinova under the brand name DHActive(R) for use in functional foods and dietary supplements. Martek has previously disclosed that it filed a similar suit in the United States in September of 2003.
Martek specializes in the development and sale of nutritional fatty acids, including docosahexaenoic acid (DHA), an omega-3 fatty acid. Numerous United States, European and Asian patents relating to Martek's DHA technology have been issued to Martek, including those that it has asserted have been infringed by Nutrinova.
Martek Biosciences Corporation develops, manufactures and sells products from microalgae. The Company's products include: (1) specialty, nutritional oils for infant formula that aid in the development of the eyes and central nervous system in newborns; (2) nutritional supplements and food ingredients that may play a beneficial role in promoting mental and cardiovascular health throughout life; and (3) new, powerful fluorescent markers for diagnostics, rapid miniaturized screening, and gene and protein detection.
This press release contains forward-looking statements regarding the commercialization of Martek's products. Such statements involve risks and uncertainties that could cause future actual results to differ due to a variety of risk factors, including without limitation those factors set forth in Martek's filings with the Securities and Exchange Commission.